MORC3 and dermatomyositis: As shown in Figure 3, serum miR-150-5p levels were significantly downregulated in DM patients with anti-NXP2 antibodies (3.58 ± 2.02, 11 cases) compared with those without anti-NXP2 antibodies (6.19 ± 5.27, 38 cases; P = 0.047) (Figure 3(a)).